bpc 157 human clinical evidence safety fda status BPC-157 Legal Status: Regulations and Compounding bpc-157 human clinical trials evidence
Description
AOD-9604 is a synthetic research peptide fragment derived from the C-terminal section of human growth hormone, studied for its potential role in fat metabolism and lipolytic pathways
International journal of molecular sciences, 19(7), 1987.
Now 72 hrs after it started (96hrs post vaccination) and is slightly improved
European Journal of Pharmacology, 833, 274289
Healthcare workers showed a higher incidence rate for adverse events, serious adverse events, as well death after vaccination
